Home > Insider Trading > Esperion Therapeutics Inc.

Esperion Therapeutics Inc. (ESPR)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
21 - 30
Next >>

Esperion Therapeutics, Inc. (ESPR): Are Hedge Funds Right About This Stock?

Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...

Keep Reading →

July 30th, 2021 - Hedge Funds News

Is It Too Late to Buy Esperion Therapeutics (ESPR) Stock?

Wasatch Micro Cap Value Fund recently released its Q4 2020 Investor Letter, a copy of which you can download here.

Keep Reading →

April 2nd, 2021 - Hedge Fund Investor Letters News

Is Esperion Therapeutics (ESPR) a Smart Long-term Buy?

Wasatch Micro Cap Fund recently released its Q4 2020 Investor Letter, a copy of which you can download here.

Keep Reading →

February 26th, 2021 - Hedge Fund Investor Letters News

Is Esperion Therapeutics (ESPR) Stock a Buy For 2021?

Baron Discovery Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here.

Keep Reading →

February 3rd, 2021 - Hedge Fund Investor Letters News

Is ESPR A Good Stock To Buy Now?

We at Insider Monkey have gone over 817 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September...

Keep Reading →

December 16th, 2020 - Hedge Funds News

Should Value Investors Buy Esperion Therapeutics (ESPR) Stock?

Baron Discovery Fund recently published its third-quarter commentary – a copy of which can be downloaded here.

Keep Reading →

December 2nd, 2020 - Hedge Fund Investor Letters News

Do Hedge Funds Love Esperion Therapeutics (ESPR)?

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Keep Reading →

October 13th, 2020 - Hedge Funds News

Were Hedge Funds Right About Betting On Esperion Therapeutics (ESPR)?

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).

Keep Reading →

August 7th, 2020 - Hedge Funds News

Esperion Therapeutics, Inc. (ESPR): Hedge Funds Are Getting Bullish

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.

Keep Reading →

June 23rd, 2020 - Hedge Funds News

Were Hedge Funds Right About Selling Esperion Therapeutics (ESPR)?

Coronavirus is probably the #1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW.

Keep Reading →

April 18th, 2020 - Hedge Funds News